The judge assigned to handle the Yaz Lawsuit, Multi District Litigation, often referred to as the Yaz Class Action Lawsuit, has granted more time to Bayer, the maker of Yaz and the plaintiff law firms representing over 11,000 claimants, to settle the case before a trail begins.

The issue with Yaz that has led to the massive number of lawsuits being filed stems from one of the ingredients in Yaz, drospirenone. Drospiredone has been linked to an increased incident of blood clots occurring in women who take birth control pills containing this ingredient. The primary ingredients in Yaz are a generic form of estrogen that has been used in birth control pills for many years and the additional ingredient Drospiredone.

For more information on Yaz Lawsuits or to arrange a consultation with a Yaz Lawyer contact Best Legal Source at (800) 611-7080

Technorati Tags: Yaz Lawsuit

Yaz Class Action Lawsuit

Yaz Class Action Lawsuit 05/15/2012:  Although a Yaz Lawsuit Multi District Litigation has been formed and differs from a Class Action Lawsuit, many people still refer to the Yaz Lawsuit Multi District Litigation as the Yaz Class Action Lawsuit.

Although a Multi District Litigation has been formed, new Yaz Lawsuits continue to be filed.  In early April a Yaz Lawsuit was filed against BAYER CORPORATION, an Indiana corporation; Bayer Healthcare Pharmaceuticals Inc., a Delaware corporation; Bayer Healthcare, LLC, a Delaware limited liability company; Berlex Laboratories International, Inc., a Delaware corporation; Bayer Schering Pharma AG, a German corporation; Bayer AG, a German corporation; Schering AG, a German corporation; McKesson Corporation, a Delaware corporation; and Does 1-50, Defendants., Defendants on behalf of 13 Plaintiffs.

The claims against the defendants include : In representations to Plaintiff and/or Plaintiffs healthcare providers and/or the FDA, Defendants fraudulently concealed and intentionally omitted the following material information:

That Yasmin is not as safe as other available contraceptives;

That the risks of adverse events with Yasmin (drospirenone and ethinyl estradiol) was higher than those with other available contraceptives;

That the risks of adverse events with Yasmin was not adequately tested and/or known by Defendants;

Plaintiff was put at risk of experiencing serious and dangerous side effects including but not limited to pulmonary emboli, as well as other severe and personal injuries, including future thromboembolic events, which are permanent and lasting in nature, physical pain and mental anguish;

That patients needed to be monitored more regularly than normal while using Yasmin;

That Yasmin was manufactured, marketed, produced, and distributed negligently;

That Yasmin was manufactured, marketed, produced, and distributed defectively;

That Yasmin was manufactured, marketed, produced, and distributed improperly;

That Yasmin was designed negligently; j. That Yasmin was designed defectively; k. That Yasmin was designed improperly.

If you took Yaz or Yazmin and experienced a severe side effect contact us today for more information on filing a Yaz Lawsuit  (800) 611-7080

Technorati Tags: Yaz Class Action Lawsuit

Yaz Lawsuit

Yaz Lawsuit Filed in New Jersey 05/15/2012:  A new Yaz Lawsuit was filed in the United States District Court, D. New Jersey on or about April 30^th, 2012 against Bayer Healthcare Pharmaceuticals, Inc., Berlex Laboratories, Inc., Berlex, Inc., Bayer Pharma Ag, Bayer Ag, Jane Doe Distributors on behalf of a female plaintiff alleging injuries and other damages caused by the prescription drug Yaz.

As with most of the thousands of Yaz Lawsuits already filed, this new Yaz Lawsuit is primarily based on the manufacturer and its agents failure to warn of the potential risks associated with taking Yaz as well as marketing practices related to Yaz. Some of the allegations in the complaint include:

Despite the wealth of scientific evidence, Defendants have not only ignored the increased risk of the development of the aforementioned injuries associated with the use of Yasmin®, Yaz®, and Ocella®, but they have, through their marketing and advertising campaigns, urged women to use Yasmin®, Yaz® or Ocella® instead of birth control pills that present a safer alternative.

Over-Promotion of Yasmin® and Yaz®

Defendants market Yasmin® and Yaz® as effective for the treatment of premenstrual dysphoric disorder (hereinafter referred to as “PMDD”), premenstrual syndrome (hereinafter referred to as “PMS”) and moderate acne, in addition to its FDA- approved use as an oral contraceptive.

Defendants market Yasmin® and Yaz® as providing the same efficacy as other birth control pills in preventing pregnancy, but with additional benefits.

Defendants market Yasmin® and Yaz® as lacking certain side-effects, such as weight gain, bloating, and water retention, common to many other oral contraceptives.

However, because Yasmin®, Yaz®, and Ocella® contain the fourth generation progestin drospirenone, which is a diuretic, these drugs present additional health risks not associated with other birth control pills.

If you took Yaz or Yazmin and suffered adverse side effects please call (800) 611-7080  for more information about filing a Yaz Lawsuit.

Technorati Tags: Yaz Lawsuit

Yaz Lawsuit

In addition to the nearly 12,000  Yaz and Yasmin Lawsuits that have been filed  a new Yaz Lawsuit and Yasmin Lawsuit was filed in the Superior Court of California, Los Angeles County in late April. This new Y Lawsuit names Bayer Healthcare LLC; Bayer Pharmaceuticals Corporation; Bayer Healthcare Pharmaceuticals Inc.; Berlex Laboratories, Inc.; Berlex, Inc.; Bayer Schering Pharma AG; Bayer AG; McKesson Corporation; Barr Laboratories, Inc; Barr Pharmaceuticals LLC; Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd as defendants. The Yaz Lawsuit wsa filed on behalf of approxitmately 34 Plaintiffs.

As with previous Yaz Lawsuits this suit alleges that the  Defendants knew and were aware or should have been aware that the PRODUCTS had not been sufficiently tested, was defective in its design and testing, and lacked adequate and sufficient warnings. The suit also alleges that the Defendants knew or should have known that the PRODUCTS had a potential to, could, and would cause severe and grievous injury and death to the users of said product, and that it was inherently dangerous in a manner that exceeded any purported, inaccurate and downplayed warnings

The suit in question is bases on numerous allegations other than those listed above with the majority of the allegations in the complaint being centered around the defendants “Failure to Warn” the plaintiffs of the risks associated with the use of Yaz or Yazmin.

If you took Yaz or Yazmin and suffered a blood clot reltated injury such as a DVT, a pulmonary emoblishm, a stroke or other blood clot related injury it is  not too late to file a Yaz Lawsuit or Yazmin Lawsuit to be compensated for your medical bills, pain and suffering and other loses. Contact (800) 611-7080 for more information.

Technorati Tags: Yasmin Lawsuit, Yaz Lawsuit

Yaz Lawsuit

Yaz Lawsuit- 05/15/2012:   Although a current Yaz Lawsuit Multi District Litigation is current underway and the maker of Yaz is working to settle the large volume of current Yaz Lawsuits that have been filed, new  lawsuits continue to be filed in multiple states.

In early April a Yaz Lawsuit was filed against Bayer Healthcare Pharmaceutical Inc. on behalf of a plaintiff alleging injuries suffered from the use of Yaz. The Yaz Lawsuit was filed in the United States District Court, E.D. Louisiana.

The plaintiff alleges, among other things that the defendant Bayer Healthcare Pharmaceutical Inc. Defendants knew or should have known that YAZ/YASMIN had a potential to, could, and would cause severe and grievous injury and death to the users of said product, and that it was inherently dangerous in a manner that exceeded any purported, inaccurate, and/or down-played warnings.

In representations to Plaintiff, her healthcare providers, and/or the FDA, Defendants also fraudulently concealed and intentionally omitted the following material information:

That YAZ/YASMIN are not as safe as other available contraceptives;

That the risks of adverse events with YAZ/YASMIN (drospirenone and ethinyl estradiol) was higher than those of other available contraceptives;

That the risks of adverse events with YAZ/YASMIN was not adequately tested and/or known by Defendants;

Plaintiff was put at risk of experiencing serious and dangerous side effects including, but not limited to gallbladder disease, as well as other severe and personal injuries, physical pain and mental anguish;

That patients needed to be monitored more regularly than normal while using YAZ/YASMIN; and

That YAZ/YASMIN was designed, tested, manufactured, marketed, produced, distributed and advertised negligently, defectively, fraudulently and improperly. Defendants were under a duty to disclose to Plaintiff and her physicians, hospitals, healthcare providers and/or the FDA, the defective nature of YAZ/YASMIN.

Defendants had sole access to material facts concerning the defective nature of the product, and its propensity to cause serious and dangerous side effects, and hence, cause damage to persons who used YAZ/YASMIN, including Plaintiff.

If you took Yaz or Yasmin and experienced an injury related to these drugs please contact us for more information on filing a Yaz Lawsuit. 1 (800) 611-7080

Technorati Tags: Yaz Lawsuit

Yaz Lawsuit

Yaz Lawsuit Update 05/14/2012: Although Bayer has indicated that it plans to start making settlement offers on the 11,000 plus Yaz Lawsuits it currently faces, new Yaz Lawsuits are still being filed. On or about April 04/24/12 Case Number 3:12-cv-20100-DRH-PMH was filed on behalf of 4 adults and one minor child. The Yaz Lawsuits were filed in the United States District of Court of Minnesota.

The Yaz Lawsuit was filed on behalf of all plaintiffs involved as a single lawsuit although each plaintiffs damages were set forth individually. Common to all plaintiffs complaints were:
This Yaz Lawsuit was filed based on the following cause(s) of action: strict products liability, breachof express and implied warranty, negligence, negligence per se, fraudulent misrepresentation, fraudulent concealment, fraud, negligent misrepresentation, and unjust enrichment brought by Plaintiffs for damages associated with their ingestion of the pharmaceutical drug YAZ/Yasmin, also known generically as drospirenone and ethinyl estradiol .

It has yet to be determined how many more Yaz Lawsuits Bayer will have to face. It is clear that the case is not near an end despite the fact that Bayer is already in settlement talks with a large number of plaintiffs that have already filed a yaz lawsuit.

For more information or to inquire about filing a Yaz Lawsuit contact 1(800) 611-7080

Technorati Tags: Yaz Lawsuit, Yaz Lawsuits

Paxil Lawsuit

Paxil Lawsuit: Taking Paxil while pregnant can affect the development of the fetus. This then results in the Paxil bad side effects. Taking Paxil during the first trimester is especially dangerous. When babies are exposed to Paxil during the first trimester, they may be born with heart problems such as atrial or ventricular septal defects. These defects are holes in the wall that separates the heart chambers. When this heart problem exists, it makes the organ work harder than it should. It is possible that over time this defect may correct itself, but may be so severe that it will require surgery. Paxil Lawsuit

Another negative Paxil side effect includes abnormalities in the development of the abdomen. A type of abdominal wall defect linked to the use of Paxil is when the intestines, liver and other organs stay outside the abdomen in a sac. In a Paxil baby, the muscles in the abdominal wall (umbilical ring) do not close properly. Once the baby is born and doing well, this side effect of Paxil will require corrective surgery. This surgery creates a cavity inside the abdomen to contain the intestinal contents. If your child has suffered from a Paxil birth defect, contact a Paxil lawyer for a consultation.

Our use of the term or terms Paxil Lawsuit is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Paxil Lawsuit visit our site often.

Technorati Tags: Paxil lawsuit

Resources
To see a diagram of a Venous Thrombosis visit http://www.nuvaringlawsuit.info/wp-content/uploads/2012/05/DVT-300×230.jpg

For more information on the study visit http://www.nuvaringlawsuit.com

Technorati Tags: Nuvaring Class Action Lawsuit, Nuvaring Lawsuit, Nuvaring Lawyer

The judge assigned to handle the Yaz Lawsuit, Multi District Litigation, often referred to as the Yaz Class Action Lawsuit, has granted more time to Bayer, the maker of Yaz and the plaintiff law firms representing over 11,000 claimants, to settle the case before a trail begins.
To date 651 cases have been settled for a total of $142,000,000. This represents an average per Yaz Lawsuit case settlement of approximately $218,000 dollars. Current estimates that Bayer will have to spend in excess of two and a half billion dollars to settle the remainder of the current pending Yaz Lawsuit cases.

Although the United States Food and Drug Administration did not officially announce the problems associated with Yaz until 2011, numerous lawsuits had already been filed. The issue with Yaz that has led to the massive number of lawsuits being filed stems from one of the ingredients in Yaz, drospirenone. Drospiredone has been linked to an increased incident of blood clots occurring in women who take birth control pills containing this ingredient. The primary ingredients in Yaz are a generic form of estrogen that has been used in birth control pills for many years and the additional ingredient Drospiredone.

As early as 2011 there were reports of women and teenage girls dying from blood clot related medical problems that have now officially been linked to Yaz. When the problems were first reported the manufacturer denied any responsibility for the deaths and other medical issues related to Yaz however, the drug company is working diligently with those who have filed Yaz Lawsuits to settle the cases without the need for a trail, although they still refuse to admit any liability or wrong doing.

New Yaz Lawsuits are still being filed. Given that there was no official recognition of the relationship between Yaz and blood clot related medical problems until 2011, the time limit to file Yaz Lawsuits has not expired. Women who took Yaz and suffered blood clot related problems such as strokes, deep vein thrombosis, pulmonary embolisms.

For more information on Yaz Lawsuits or to arrange a consultation with a Yaz Lawyer contact Best Legal Source at (800) 611-7080

Technorati Tags: Yaz Lawsuit

Paxil Birth Defects

Alerts have been issued by the U.S. Food and Drug Administration (FDA) to physicians and their patients that risks to the fetus exist when women take Paxil® during the first three months of pregnancy. These serious risks include Congenital Heart Defects, Persistent Pulmonary Hypertension (if taken during the last months of pregnancy), Neural Tube Defects and Abdominal and Cranial birth defects. The FDA requested that the manufacturer reclassify Paxil® from a Pregnancy Category C to Pregnancy Category D. Pregnancy Category D represents drugs which have caused or may cause an increased risk of human fetal malformations and irreversible damage. If you believe your child has suffered a birth injury because of Paxil®, A Paxil Birth Defects Lawyer can help you consider your legal options.
Paxil Birth Defects Lawyer, Paxil Birth Defects Lawyers and Paxil Birth Defect Lawyers are terms used to describe the legal process and service provided by an attorney experienced in Paxil lawsuits or similar cases. The use of these terms and any other phrases containing the word Paxil® does not imply any connection or relationship between the makers of Paxil® and Best Legal Source.

The owners of this website are not the makers of Paxil® and have no affiliation with the makers of Paxil®. If you are searching for information directly from the makers of Paxil®, this is not their website. Please refer to the Paxil® manufacturer’s website if you are seeking information from the company that makes Paxil®. For even further information concerning the drug Paxil®, visit the website of the U.S. Food and Drug Administration (www.fda.org).

Have you taken the medication Paxil® while pregnant and delivered a child with a birth defect? Please contact a Paxil Birth Defect Lawyer by filling out the form to the right or calling 800-611-7080. You may be eligible to compensation and we will be there to help.

Our use of the term or terms Paxil Lawsuit is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Paxil Lawsuit visit our site often.

Technorati Tags: Paxil lawsuit

Yaz Lawsuit: Yaz Lawyers are reviewing cases involving individuals who took the oral contraceptive Yaz and suffered from blood clots and their complications. In 2011, the U.S. Food and Drug Administration informed the public about new information concerning birth control pills containing the hormone drospirenone. The ongoing safety review states that this type of contraceptive shows a possible increased risk of blood clots. These side effects could require the expertise of Yaz Lawyers. Experienced Yaz Lawyers can discuss your legal rights regarding financial compensation and determine the strength of your claim. Call Best Legal Source at 800-611-7080 or complete the contact form to the right and a representative will connect you with qualified Yaz Lawyers.

Yaz Lawyers can assist individuals who have suffered from the side effects of blood clots. Contact your doctor right away if you notice persistent leg pain, severe chest pain or shortness of breath. Because of the possible increased risk of blood clots, women should pay close attention to signs of these symptoms and report any side effects. Financial compensation for costly medical bills, along with the loss of your health, may be recovered by speaking with qualified Yaz Lawyers.

Yaz Lawyers and Yaz Lawyer are general terms used to describe the legal process offered by a lawyer experienced with Yaz lawsuits and similar cases. We do not use these terms to imply a connection between Best Legal Source and the manufacturers of Yaz. This website was created for the sole purpose of assisting individuals who have suffered as a result of taking this medication. Let Best Legal Source begin the search to find knowledgeable Yaz Lawyers for you.

Our use of the term or terms Yaz Lawsuit is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Yaz Lawsuit visit our site often.

Technorati Tags: Yaz Lawsuit

Yaz Lawsuit: The mission of Best Legal Source is to assist women who developed blood clots or conditions caused by blood clots to find the best possible counsel of Yaz Lawyers to handle their Yaz Class Action.  Not all attorneys have the experience with complex litigation.  Let Best Legal Source put you in touch with an experienced Yaz Lawyer significantly experienced in Yaz Class Action lawsuits.  Contact Best Legal Source today!  We can be reached through the form above or at 800-611-7080.  Time is a vital factor in joining a Yaz Class Action Lawsuit. Call today!

Vascular inflammation may also influence arterial vasomotor function through several possible mechanisms. Increased concentrations of thromboxane A2 and its metabolites produced in acute coronary syndromes mediate further platelet aggregation as well as arterial vasoconstriction. Leukocytes also produce en- dothelin-1, a potent modulator of vasoconstriction. In addition, certain inflammatory cytokines may increase vascular smooth muscle cell reactivity, as demonstrated in an animal model with IL-1. Finally, inflammatory infiltrates have been documented in the arterial adventitia with vascular nerve involvement and thus have been hypothesized to directly stimulate coronary vasospasm.

Thus, the ‘‘vulnerable’’ plaque is typified by a large lipid pool and a thin or absent fibrous cap, as well as the predominance of inflammatory mono­cytes, the expression of HLA-DR antigens, and a decrease in the number smooth muscle cells. Each of these features either directly, or through mechanisms outlined above, implicate an inflammatory contribution. While other factors, such as shear stress and vasospasm, may also contribute to plaque destabilization, the participation of inflammation in this process appears central.

Yaz Lawsuit News: Information and News

Yaz Lawsuit: In spite of continued advancements in the management of acute ischemic heart disease, morbidity and mortality due to atherosclerotic vascular disease continue to rise globally. Thus, the impetus for improving our strategies for the prevention and management of atherosclerosis has remained strong. In this re­gard, laboratory and experimental research describing key processes in the initia­tion, progression, and destabilization of the atheroma have pointed to novel direc­tions for cardiovascular evaluation and management. In particular, recognition of the role of inflammation in atherothrombosis has directed attention to inflam­matory mediators and indicators as potential targets for risk assessment and for treatment.

Epidemiological data have established a well-characterized set of vascular risk factors, including advanced age, tobacco use, obesity, diabetes, hypertension, and dyslipidemia. However, up to one-third of first coronary events occur among individuals without these traditional risk factors. Researchers have thus sought to identify inflammatory indicators that might add to these clinical factors for predicting myocardial infarction and stroke. Candidate markers have included several of the cytokines that promote the recruitment of monocytes in response to endothelial cell dysfunction; intercellular adhesion mol­ecules that mediate the migration of activated monocytes into the subendothelial space; enzymes that might compromise the integrity of the protective fibrous cap, as well as the acute-phase proteins that are produced and released into the systemic circulation in response to inflammatory cytokines. As an amplified and readily quantified inflammatory signal, the prototypical acute- phase reactant C-reactive protein (CRP) has been a focus of clinical investigation to date.

Yaz Lawsuit News: News and Information

Yaz Lawsuit: With systemic levels that are dependent on the rate of de novo hepatic production, CRP levels remain stable over long periods of time in the absence of new stimuli. However, in response to acute tissue injury, infection, or other inflammatory stimuli, CRP levels rise several hundred-fold. As such, CRP and its acute-phase counterpart, serum amyloid A, have been useful in fol­lowing disease activity in chronic inflammatory conditions such as systemic lu­pus, inflammatory bowel disease, and rheumatoid arthritis. Traditional semiquantitative latex agglutination or standard turbidometric methods have been adequate to evaluate such marked elevation of CRP in these disease processes. In contrast, the development of high-sensitivity assays for CRP (hs-CRP) has now enabled detection of CRP within the normal range for healthy individuals. Further, the introduction of high through-put methods with high ana­lytical sensitivity and reproducibility has provided a simple clinical tool to care­fully evaluate the extent of underlying systemic inflammation.

Cross-sectional studies have evaluated the association between elevated levels of CRP and the presence and extent of atherosclerotic vascular disease. Elevated levels of CRP have been demonstrated among patients with acute myocardial ischemia and infarction, as well as among individuals with stable coronary heart disease (CHD). In a cross-sectional survey of 388 British men aged 50 to 69 recruited from general practice registers, Mendall and col­leagues demonstrated a 1.5-fold increase in the prevalence of CHD for each dou­bling in the levels of hs-CRP (95% CI, 1.25-1.92). Nevertheless, such cross-sectional data cannot exclude the possibility of important confounding, nor do they establish a cause-and-effect relationship. For example, blood levels of hs-CRP have been found to increase with age, body-mass index, and tobacco use, as well as in response to myocardial tissue necrosis. In contrast, prospective studies can control for such confounders and have been important in exploring the independent prognostic information offered by inflammatory markers.

Our use of the term or terms Yaz Lawsuit is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Yaz Lawsuit visit our site often.

Technorati Tags: Yaz Lawsuit

Heart Attack Victim

Actos Lawsuit News 5/3/2012: Did you take Actos? Please contact us today if you took Actos and later experienced harmful side effects. We will connect you with a lawyer that is experienced in complex litigation that may be able to help you recover monetary damages.
Actos Lawsuit: The United States Food and Drug Administration issued a Safety Announcement on June 15th 2011 warning the public about a link between the drug Actos and Bladder Cancer. This warning has led to the investigation of a new Actos Lawsuit by attorneys across the United States. This is not the first type of Actos Lawsuit that has been investigated and filed on behalf of people who have been injured by the use of Actos. This latest Actos Lawsuit centers around the link between Actos and Bladder Cancer. If you took Actos and later developed Bladder Cancer please contact us today so that we can make arrangements for a free consultation with an Actos Attorney regarding your potential Actos Lawsuit.

Given the monetary pressures in today’s medical practice, some physicians are over booked and cannot see the allotted number of patients scheduled without delays. The theory behind this schedule is the expectation that a number of patients will not show for their appointment, allowing the physician to stay true to the schedule and not fall behind.

However, sometimes all of the patients do show, and the physician is delayed. Even with a carefully thought out schedule, emergencies may arise and some visits unexpectedly take longer than scheduled. The physician wants to devote the time and attention required for each individual. After all, you also expect the same time and attention during your visit. Even the most conscientious physician may find himself running behind in a busy medical practice. This lateness should be recognized by the physician who will often acknowledge it with an apology. If you find it distressing to wait more than fifteen minutes (a reasonable time to wait), you should discuss your feelings with your physician, who often can arrange an appointment at the beginning of the schedule when he will almost be guaranteed to be on time.

Actos Lawsuit News: More information about your search

Actos Lawsuit: You may need to be referred to an oncologist, a physician specialist in the medical therapy of cancer. At times, a referral to a radiation oncologist, a specialist who treats cancer with radiation, may be required. Other individuals may need to be consulted as well. It is important for your urologist to keep your primary care physician up to date so that he can coordinate your care and if required by your insurance plan, make the appropriate referrals. On a regular basis, magazine articles, books, and television shows implore those with major illnesses to seek out a second opinion. The general consensus is there is much to be gained and little to be lost, so why not seek out a second opinion? The issue certainly is more complicated than generally addressed, and deserves a review.

In general, a competent physician will recommend a second opinion if there is uncertainty regarding your care. This uncertainty could involve the pathology report or debate regarding the most appropriate treatment options. Certainly if the pathology report is in question, a second opinion is mandatory! Your urologist should be able to spell out his treatment plans for you, what to expect and what alternatives may be required, depending on the seriousness of your disease. The plan may change over time as your disease improves or worsens.

You may need a second opinion if you are not doing well and your physician is unable to provide satisfactory explanations and solutions. Occasionally, your urologist may recommend a second opinion if your problem is unusual or particularly complicated. Having a physician you can trust is mandatory when dealing with cancer. Don’t let anyone pressure you into a second opinion if you feel confident in your physician’s abilities. On the other hand, if you are uncomfortable with your progress or a treatment recommendation, if you are not satisfied with the explanations given to you, don’t hesitate to seek out a second opinion. Your urologist should not feel threatened by this request as he wants you to feel comfortable with the plan of action. Only by partnering with your physician can he be most effective.

Actos Lawsuit News: Additional Information and Resources

Actos Lawsuit: Many physicians may feel slighted when a patient requests a second opinion. Your urologist may feel somehow you don’t trust his explanations, skill, or judgment. On the other hand, when a new patient faces a difficult or unexpected diagnosis, the urologist may find the request not at all unusual. It is important you explain to your urologist why you feel a second opinion is warranted. Urologists are professionals and will graciously facilitate your request. The experienced urologist comes to realize that despite his best efforts, some patients will seek a second opinion. If a patient is particularly concerned or nervous about a proposed treatment regimen, your urologist may welcome your request. Your urologist should facilitate your second opinion by sending appropriate records and telling you whether or not it is necessary for you to bring X rays or pathology slides with you. Your primary care physician may need to be contacted for the referral if your insurance requires it.

Often, the urologist may believe the second opinion is unnecessary and will delay treatment. He may be concerned you will not only have a second opinion, but transfer your future care to the urologist providing the second opinion. He may believe that you may get bad advice. It is possible he may feel threatened the next urologist will not agree with his work up or care of you to date. Start by asking your primary care physician. You may be able to see another urologist in your community. Do not see another urologist in the same group as a conflict of interest may deter a different opinion. If you are considering a different course of action, such as radiation or chemotherapy, a referral to the appropriate specialist should be made. Cancer unfortunately is a common disease affecting almost all animals. People are equally susceptible; approximately one in three will be afflicted at some time in their life. In this chapter, we will review basic information regarding the bladder, bladder cancer, and cancer in general, including what causes it and some parameters used to determine how serious it is.

Our use of the term or terms Actos Lawsuit is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Lawsuit visit our site often.

Technorati Tags: Actos Lawsuit

Byetta Attorneys: The explosive growth of genetics in the twentieth century showed that all organisms, including even simple single-cell organisms such as bacteria and baker’s yeast, rely on genes as the templates for making progeny. Also, virtually all organ­isms, ranging from bacteria to humans, were found to have evolved elaborate mating mechanisms. In every case, the same underlying motive was apparent: Mating enabled the exchange and mixing of genes between members of a species. Since all species comprised populations of genetically heterogeneous individuals, mating afforded the oppor­tunity of testing novel combinations of genes. Novel gene combinations might yield offspring that were more fit than their parents. That increased fitness, in turn, powered the engine of evolution.

Controlled mating of genetically distinct individuals be­came a powerful tool for studying the behavior of genes—in particular, how the genes carried by one parent in a mating blended with those of its partner. While bacteria and yeast cells were found to mate with one another, cells prepared from mammalian tissues lacked that ability. The only matings naturally allowed between mammalian cells involved the fusion of sperm and egg. These facts prevented re­searchers from observing the outcome of mating dissimilar kinds of cells—bone cells from one person with bone cells from another, or bone cells with muscle cells of the same person.

Under some conditions, these fusions could involve dozens of cells simultaneously, yielding enormous cells that were far too large and unwieldy to grow and divide. Far more interesting were the fusions involving only pairs of cells. Such two-cell hybrids could grow and divide, transmitting to offspring the pooled genes originating from the two parent cells. The outcome of these hybridizations seemed obvious. Cancer is a dominating force in the body, and tumor cells in­variably grow more vigorously than their normal counter­parts. Therefore, if a cancer cell was fused to a normal cell, the potent genes in the cancer cell would dominate over the weaker genes carried by its normal partner. The hybrid cell carrying both sets of genes should, by this logic, behave like the cancerous parent. Among other things, this hybrid cell should be able to seed tumors when injected into a mouse or rat.

The genes present in the normal cells seemed to be slowing down growth. They acted, in effect, like brakes that allowed cells to counteract any tendencies to lurch forward into runaway growth. Can­cer cells, having lost these genes, had lost their braking mechanism. Once the braking mechanism was reinstalled in the cancer cells by the cell hybridization trick, the cancer cells’ forward momentum ground to a lialt. Now these run­aways had a means of controlling the uncontrollable—their drive to grow without limit.

Byetta Attorneys News: More information about your search

Byetta Attorneys : Now there were two groups of genetic actors on the can­cer stage, each specifying a distinct part of the machinery that governed cell growth. The proto-oncogenes operated like the accelerator pedal in a car; mutant oncogenic versions of these genes seemed to result in pedals that were stuck to the floor. Conversely, the tumor suppressor genes worked like brakes. As normal cells developed into cancer cells, they might shed or inactivate these tumor suppressor genes, resulting in defective braking mechanisms. Runaway cell growth seemed to be explainable by either mechanism.

The existence of two diametrically opposite explanations of cancer formation demanded some resolution. Did some kinds of tumor cells rely on one mechanism to achieve ma­lignant growth while others used the alternative mechanism? Or did both mechanisms operate together within cancer cells? Perhaps stuck accelerators and faulty brakes conspired to create cancerous growth. The answers to these questions did not fall in place im­mediately. But the discovery of tumor suppressor genes did open the door to another aspect of human cancer—its heritability. Cancer often runs in families, and these genes provided an explanation for the origin of many kinds of familial cancer.

Byetta Attorneys News: Additional Information and Resources

Byetta Attorneys: But the most convenient and therefore most frequently used way for a cell to rid itself of a gene is more subtle. Most often, a gene will suffer only a single base change—a point mutation—in one of its sequences. Such a subtle change may have deadly consequences if it strikes a critical sequence in the gene. Point mutations may insert inappropriate punctua­tion marks into the middle of a gene; because these marks normally signal the end of a gene, they may terminate the read-out of the gene prematurely, causing truncation of the protein specified by this gene. Other times, the protein prod­uct of the gene may suffer some change in its string of amino acids that renders it nonfunctional. The result of all these mutations, large and small, will be the same: The cell will lose the services of the mutated gene.

In reality, losing the services of a tumor suppressor gene is more complicated than implied here. Almost all genes in our cells are present in two redundant copies, one deriving originally from our mother’s genes, the other from our father. In the case of tumor suppressor genes, this two-copy system offers a measure of protection to the cell. If one copy of a suppressor gene is accidental lost, the remaining gene copy serves as a perfectly adequate backup. Almost always, half a brake lining is as good as a whole one in slowing down cell growth.

Tumor cells usually resort to a more expedient way of eliminating the second copy of a tumor suppressor gene. Their strategy depends on the fact that the two partners in a human chromosome pair (such as the two thirteenth chromosomes, each of which carries an Rb gene copy) often line up next to one another in parallel array, look each other over, compare their respective DNA sequences, and then swap ge­netic information. One frequent result is that a gene se­quence present on one chromosome will now replace the corresponding sequence carried by its partner. Before this in­formation transfer, two distinct versions of a gene may have resided on the two paired chromosomes; afterward, one of these versions is lost, being replaced by a duplicated version of the gene originally present on the other chromosome. The result is two identical copies of a gene in a cell that previ­ously carried two dissimilar versions.

Our use of the term or terms Byetta Attorneys is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Byetta Attorneys News visit our site often.

Technorati Tags: Byetta Attorneys

Pancreatic Cancer

Byetta Class Action News – 5/2/2012: Did you take Byetta? Please contact us today if you took Byetta and later experienced harmful side effects. We will connect you with a lawyer that is experienced in complex litigation that may be able to help you recover monetary damages.

Byetta Class Action: Tumor cells usually resort to a more expedient way of eliminating the second copy of a tumor suppressor gene. Their strategy depends on the fact that the two partners in a human chromosome pair (such as the two thirteenth chro­mosomes, each of which carries an Rb gene copy) often line up next to one another in parallel array, look each other over, compare their respective DNA sequences, and then swap ge­netic information. One frequent result is that a gene sequence present on one chromosome will now replace the corresponding sequence carried by its partner. Before this information transfer, two distinct versions of a gene may have resided on the two paired chromosomes; afterward, one of these versions is lost, being replaced by a duplicated version of the gene originally present on the other chromosome.

Precancerous tumor cells on their way to becoming actively malignant will often use this trick to eliminate both copies of a tumor suppressor gene that has been holding back their growth. They will first mutate to inactivity one copy of the gene and then eliminate its partner through this loss-of-heterozygosity homogenization. Importantly, the chromosomal swaps that generate this homogenization often involve large regions of the chromosome surrounding the tu­mor suppressor gene, not just the gene itself. Hundreds of genes residing to the left and the right of the tumor suppres­sor gene on a chromosome will also become homogenized. Of course, the homogenization of neighboring gene copies is irrelevant for the growth of the developing tumor cells. These neighboring genes are nothing more than innocent by­standers. It is realty only the tumor suppressor gene that the tumor cell is intent on eliminating through use of the homog­enization trick.

Two things changed in modern times. We now live much longer than we used to. By the middle of the twentieth century, many of us began to live for seventy or eighty years, an age when this disease strikes frequently. A hundred years earlier, relatively few survived long enough to confront it. Our diet also changed from one heavy in grains and vegetables to fare that increasingly emphasized meat and large amounts of fat. The effects of diet are apparent from epidemiology: There are regions of Africa whose inhabitants follow a diet based al­most exclusively on vegetables and grains. These people run a risk of colon cancer that is less than one-tenth of that seen in the West.

Byetta Class Action News: More information about your search

Byetta Class Action: Some humans make these detoxifying enzymes at high levels, while others produce them at much lower levels. These differences, which are heritable, offer us the opportu­nity to understand the roles of these enzymes in protecting cells against attack by various carcinogens. For example, do individuals with low levels of these protective enzymes con­tract cancer more often than those having high levels? In fact, some striking differences have been uncovered. Smokers who make low levels of the NAT enzyme (N-acetyl transferase) run as much as two and a half times the risk of bladder cancer compared to smokers having high levels of the NAT enzyme. Low levels of a second detoxifying en­zyme, GSTMl (glutathione-S-transferase Ml), result in a threefold increase in the risk of lung cancer. These findings suggest that we may one day be able to calculate smokers’ risk of cancer based on their lifelong cigarette consumption and their levels of detoxifying enzymes.

Some mutagens succeed in penetrating this complex array of protective devices. Having escaped inactivation, these mutagens may proceed to react with and thereby damage the DNA molecules carried in the cell’s chromosomes. Every human cell sustains thousands of such mutagenic attacks every day. But in spite of this barrage, the cell’s DNA emerges at the end of the day relatively unscathed. This discrepancy demands explanation.

Close scrutiny of the machinery used by the cell to copy its DNA molecules reveals a similar discrepancy. The process by which cells replicate DNA in preparation for cell division is prone to error. Immediately after DNA poly­merase—the enzyme responsible for DNA replication—has copied a stretch of DNA, as many as one in every thousand bases of the newly made DNA strand may be incorrect, hav­ing been mistakenly inserted by the polymerase. But as be­fore, the actual rate at which mutations accumulate in the DNA is much lower. Somehow, the vast majority of these initial copying mistakes are not perpetuated in the DNA.

This dynamic has direct consequences for tumor forma­tion: If the DNA repair process fails, large numbers of altered bases will accumulate in a cell’s DNA. This means that the rate at which mutations accumulate is influenced by at least three distinct processes: damage inflicted on the DNA by mutagens of foreign or internal origin, mistakes made during DNA copying, and defects in die DNA repair machinery responsible for erasing the damage created by mutagens or miscopying. Since mutation is the engine that drives tumor progression, all three of these processes are likely to be involved in one way or another in causing cancer.

Byetta Class Action News: Additional Information and Resources

Byetta Class Action: Knowing about mutant genes allows us to trace the roots of cancer back to discrete, identifiable changes in the central controlling molecule of the cell, its DNA. But in one sense, these genetic discoveries are sterile and uninformative. Genes are pure information, nothing more than mathemati­cal abstractions. Studied in isolation, they tell us little about the real life of the cell. Moreover, the sequence of DNA bases that constitutes a gene usually reveals little about how this gene operates. So, even after we know that one or another gene is mutated during the development of a cancer, we still understand next to nothing about the mechanisms by which this mutant gene causes abnormal cell growth. Fortunately, molecular biology provides us with a useful train of logic that leads us toward an understanding of gene function. Genes instruct the cells around them to make specific pro­teins. It is the proteins that do the work of the genes. Proteins catalyze biochemical reactions or create elaborate physical structures. To understand how a gene works, we must know intimately how its protein functions.

In one sense, the roles played by the normal versions of oncoproteins are obvious: They help the normal cell regulate its growth. Unfortunately, this statement does not take us very far; it only restates the problem, and in a way that is not terribly useful. A more productive tack is suggested by the following question: Precisely how do normal cells know when to grow and when to hold back from growth? At any moment, the great majority of cells in our body are in a quiescent state. Only in tissues that renew themselves constantly, such as the colonic epithelium, the bone marrow (which generates new blood cells), and the skin, does one find large numbers of cells actively growing and dividing.

These dramatic differences in the proliferation rates of tissues bring us back to our question: Precisely how do any of these cells know when they should grow? The issue becomes even more complicated in the case of embryonic development, where cell proliferation results in the creation of new, complex tissues rather than the maintenance of an existing tissue architecture.

Our use of the term or terms Byetta Class Action is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Byetta Class Action News visit our site often.

Technorati Tags: Byetta Class Action